Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07635784 · ClinicalTrials.gov registry record
Prospective HemorrhoIdaL EmboliSation (PILES) Registry
A clinical trial, sponsored by Joint & Vascular Institute.
- Recruiting
- Registry status
- 1,200
- Enrollment target
NCT07635784: Recruiting study, sponsored by Joint & Vascular Institute.
NCT07635784 is a clinical trial that is actively recruiting participants, run by Joint & Vascular Institute. The registered enrollment target is 1,200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07635784 is actively recruiting participants, sponsored by Joint & Vascular Institute.
- RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
Study Summary
The goal of this observational study (prospective registry) is to collect long-term real-world data on the effectiveness and safety of hemorrhoid artery embolization (HAE) for symptomatic bleeding internal hemorrhoids in adults aged 18 years or older that have not responded to medical therapy. The main question it aims to answer are: 1\) Does HAE lead to sustained improvement in bleeding (HDSS scores over 12-36 months? Participants will: * Undergo HAE as part of their routine clinical care. * Complete clinical follow-up assessments at 1, 3, 6, 12, 18, 24, and 36 months after treatment, including symptom and quality-of-life questionnaires. * Have safety outcomes tracked according to Society of Interventional Radiology guidelines. There is no comparison group; results will be analyzed to identify predictors of success and inform best practices for patient selection and treatment.
Interventions
- PROCEDURE Hemorrhoid Artery Embolization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2026-01-18 |
| Est. Completion | 2032-01 |
What NCT07635784 shows while recruiting
NCT07635784 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Hemorrhoid Artery Embolization is the first listed.
NCT07635784 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07635784 about?
NCT07635784 is a clinical study titled "Prospective HemorrhoIdaL EmboliSation (PILES) Registry". The goal of this observational study (prospective registry) is to collect long-term real-world data on the effectiveness and safety of hemorrhoid artery embolization (HAE) for symptomatic bleeding internal hemorrhoids in adults aged 18 years or older that have not responded to medical therapy. The ...
What is the current status of trial NCT07635784?
This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2026-01-18. Estimated completion is 2032-01.
What interventions are being tested in trial NCT07635784?
The interventions under investigation include: Hemorrhoid Artery Embolization (PROCEDURE).
Who is sponsoring clinical trial NCT07635784?
This trial is sponsored by Joint & Vascular Institute, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI